Gabapentin and Qualaquin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabapentin (gabapentin) and Qualaquin (quinine sulfate). Common drug interactions include renal failure among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Qualaquin. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

What is Qualaquin?

Qualaquin has active ingredients of quinine sulfate. It is often used in leg pain. eHealthMe is studying from 281 Qualaquin users. Check the latest studies of Qualaquin.



On Jul, 26, 2026

34 people who take Gabapentin and Qualaquin together, and have interactions are studied.

Gabapentin and Qualaquin drug interactions.

What are the common drug interactions of Gabapentin and Qualaquin, by gender? *:

female:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Aortic arteriosclerosis (hardening of the aortic arteries)
  4. Bedridden
  5. Cardiomegaly (increased size of heart than normal)
  6. Cerebral atrophy (decrement in size of brain)
  7. Congestive cardiomyopathy (weakening of heart muscle)
  8. Disability
  9. Drug dependence
  10. Fear

male:

  1. Abdominal pain
  2. Dyspnoea (difficult or laboured respiration)
  3. Affective disorder (mental disorder)
  4. Drug ineffective
  5. Feeling hot
  6. Head injury
  7. Lacrimation increased
  8. Nausea (feeling of having an urge to vomit)
  9. Nephrolithiasis (calculi in the kidneys)
  10. Peripheral coldness

What are the common drug interactions of Gabapentin and Qualaquin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

40-49:

  1. Affective disorder (mental disorder)
  2. Depression
  3. Drug ineffective
  4. Feeling hot
  5. Head injury
  6. Lacrimation increased
  7. Peripheral coldness
  8. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Suicidal ideation

50-59:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Death
  4. Hyperkalaemia (damage to or disease of the kidney)
  5. Renal injury (kidney injury)
  6. Septic shock (shock due to blood infection)

60+:

  1. Aortic arteriosclerosis (hardening of the aortic arteries)
  2. Bedridden
  3. Hospitalisation
  4. Hypertension (high blood pressure)
  5. Increased upper airway secretion
  6. Nausea (feeling of having an urge to vomit)
  7. Nephrosclerosis (hardening of the kidney due to renovascular disease)
  8. Overdose
  9. Pleural adhesion
  10. Pulmonary oedema (fluid accumulation in the lungs)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 32.35%
  2. High Blood Pressure: 10 people, 29.41%
  3. High Blood Cholesterol: 10 people, 29.41%
  4. Pain: 9 people, 26.47%
  5. Diabetes: 8 people, 23.53%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 23.53%
  7. Depression: 8 people, 23.53%
  8. Infection: 7 people, 20.59%
  9. Malaria (a parasitic disease due to mosquito bite): 7 people, 20.59%
  10. Stress And Anxiety: 6 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Qualaquin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gabapentin and Qualaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Qualaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Qualaquin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on gabapentin and quinine sulfate (the active ingredients of Gabapentin and Qualaquin, respectively), and Gabapentin and Qualaquin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: